Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas

Gastroenterology

Volumn 114, Issue 3, 1998, Pages 441-447

  Sandler, R S ^a   Galanko, J C ^a   Murray, S C ^a   Helm, J F ^a   Woosley, J T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER RISK; COLON ADENOMA; DOSE RESPONSE; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; RECTUM ADENOMA; RISK ASSESSMENT;

EID: 0031888471     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70526-8     Document Type: Article

References (33)

1. ER Greenberg JA. Baron Prospects for preventing colorectal cancer death J Natl Cancer Inst 85 1993 1182 1184
2. SJ Shiff MI Koutsos L Qiao B. Rigas Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis Exp Cell Res 222 1996 179 188
3. BS Reddy CV Rao A Rivenson G. Kelloff Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
4. GA Kune S Kune LF. Watson Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study Cancer Res 48 1988 4399 4404
5. Martinez RS McPherson B Levin JF. Annegers Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals Cancer Epidemiol Biomarkers Prev 4 1995 703 707
6. MJ Reeves PA Newcomb A Trentham-Dietz BE Storer PL. Remington Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women Cancer Epidemiol Biomarkers Prev 5 1996 955 960
7. II Peleg MF Lubin GA Cotsonis WS Clark CM. Wilcox Long-term use of nonsteroidal anti-inflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia Dig Dis Sci 41 1996 1319 1326
8. RF Logan J Little PG Hawtin JD. Hardcastle Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme BMJ 307 1993 285 289
9. JE Muscat SD Stellman EL. Wynder Nonsteroidal anti-inflammatory drugs and colorectal cancer Cancer 74 1994 1847 1854
10. L Rosenberg JR Palmer AG Zauber ME Warshauer PD Stolley S. Shapiro A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer J Natl Cancer Inst 83 1991 355 358
11. O Suh C Mettlin NJ. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 1993 1171 1177
12. ER Greenberg JA Baron DHJ Freeman JS Mandel R. Haile Reduced risk of large-bowel adenomas among aspirin users: the Polyp Prevention Study Group J Natl Cancer Inst 85 1993 912 916
13. E Giovannucci EB Rimm MJ Stampfer GA Colditz A Ascherio WC. Willett Aspirin use and the risk for colorectal cancer and adenoma in male health professionals Ann Intern Med 121 1994 241 246
14. G Gridley JK McLaughlin A Ekbom L Klareskog HO Adami DG Hacker R Hoover JF. Fraumeni Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 1993 307 311
15. A. Paganini Hill G Hsu RK Ross BE. Henderson Aspirin use and incidence of large-bowel cancer in a California retirement community J Natl Cancer Inst 83 1991 1182 1183
16. DM Schreinemachers RB. Everson Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 1994 138 146
17. MJ Thun MM Namboodiri CWJ. Heath Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
18. Y Goldberg L Qiao LL Tsai B. Rigas Caffeine potentiates the anti-proliferative effect of sulindac sulfide by increasing the amount of apoptosis in HT-29 colon adenocarcinoma cells (abstr) Gastroenterology 110 1996 A520
19. G Block AM Hartman CM Dresser MD Caroll J Gannon L. Gardner A data-based approach to diet questionnaire design and testing Am J Epidemiol 124 1986 453 469
20. G. Block Dietary guidelines and the results of food consumption surveys Am J Clin Nutr 53 1991 356S 357S
21. G Block CM Dresser AM Hartman MD. Caroll Nutrient sources in the American diet: quantitative data from the NHANESII survey. I. Vitamins and minerals Am J Epidemiol 122 1985 13 26
22. G Block CM Dresser AM Hartman MD. Caroll Nutrient sources in the American diet: quantitative data from the NHANESII survey. II. Macronutrients and fats Am J Epidemiol 122 1985 27 40
23. W. Willett Nutritional epidemiology 1990 Oxford University New York 77
24. A. Agresti Categorical Data Analysis 1990 Wiley New York 84 91
25. W Willett MJ. Stampfer Total energy intake: implications for epidemiologic analyses Am J Epidemiol 124 1986 17 27
26. B Rigas IS Goldman L. Levine Altered eicosanoid levels in human colon cancer J Lab Clin Med 122 1993 518 523
27. O Suh C Mettlin NJ. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 1993 1171 1177
28. LJ Hixson DS Alberts M Krutzsch J Einsphar K Brendel PH Gross NS Paranka M Baier S Emerson R. Pamukcu Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells Cancer Epidemiol Biomarkers Prev 3 1994 433 438
29. DL Earnest LJ Hixson DS. Alberts Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention J Cell Biochem Suppl 16I 1992 156 166
30. WR Waddell GF Ganser EJ Cerise RW. Loughry Sulindac for polyposis of the colon Am J Surg 157 1989 175 179
31. R Peto R Gray R Collins K Wheatley C Hennekens K Jamrozik C Warlow B Hafner E Thompson S Norton J Gilliland R. Doll Randomised trial of prophylactic daily aspirin in British male doctors Br Med J 296 1988 313 316
32. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 1989 129 135
33. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106